About Us

Welcome to Boston International Partners, a boutique strategic advisory firm serving as the premier bridge between Western innovation (United States & Europe) and the Yangtze River Delta (YRD) region of China—the heart of the Asian life sciences ecosystem.
 

In today’s complex geopolitical and regulatory environment, successful global expansion requires more than just high-quality science; it requires a strategic entry point and a compliance-first roadmap. We position Hangzhou, Zhejiang Province, China as the vital 'Gateway' for Western firms to access the broader YRD region—a world-class cluster encompassing Shanghai, China and Suzhou, Jiangsu Province, China that represents the majority of the country’s biomedical R&D and clinical capacity.
 

Our dual-track strategy is tailored for the 2026 global regulatory landscape:
 

1. The Hangzhou-YRD Gateway (For United States & European Innovators):
For Western IVD and precision medicine companies, national market entry in China can be a years-long challenge. We provide an exclusive 'fast-track' by leveraging the Hangzhou, Zhejiang Province, China LDT (Laboratory Developed Test) Pilot Program. We enable U.S. and European firms to achieve clinical adoption and revenue in Tier-1 hospitals years ahead of traditional national registration, using Hangzhou, Zhejiang Province as a scalable launchpad for the entire Yangtze River Delta region.
 

2. Compliance-Led Global Strategy (For International Biotech Leaders):
We navigate the intricacies of the U.S. BIOSECURE Act, China’s HGRAC (Human Genetic Resources Administration) requirements, and global data sovereignty laws. We help international firms de-risk their Western operations, ensuring that cross-border partnerships, bioinformatics workflows, and clinical expansions are built on a foundation of legal resilience, transparency, and trust.
 

At Boston International Partners, we don’t just offer consulting; we offer a secure foothold in the world’s most significant life sciences hubs.